BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cobra BioManufacturing (CBF.L) Receives Approval for Research and Development Tax Credit


3/13/2008 2:43:25 PM

Keele, UK: Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces that the French Ministry for Higher Education and Research has recognised Cobra as an approved research and development service provider. This allows companies, subject to the French General Tax Code, to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche (CIR)).

Therefore, French companies which have outsourced research and development to Cobra will be able to benefit from research and development tax credit (Le Crédit d’Impôt Recherche (CIR)).

This approval is granted for the years: 2007, 2008 and 2009.

The tax credit limit was 16 million Euros per company per year in 2007.

“This new status will allow Cobra’s clients in France to easily take advantage of the tax breaks the French Government has made available,” said Simon Saxby, COO Cobra Biomanufacturing. “Cobra is already an active player in the French market, and this development will further improve our offering to customers.”

For further information: www.enseignementsup-recherche.gouv.fr/pid20105/aide-a-la-recherche-et-au-developpement-des-entreprises.html



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES